However, more samples from patients at different stages of liver fibrosis are required to determine whether the levels of CXCR3-associated chemokines, particularly CXCL10, are able to serve as biomarkers of liver disease severity in HCV/HIV-1 infection. This evidence concerns the gene CXCL10 and Hepatic fibrosis.